<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1709234217
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DALACIN C 150 MG CAPS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CLINDAMYCIN HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Fareva Amboise" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Fareva Amboise
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER HOLDING FRANCE
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01FF01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group<strong>:</strong> Antibacterial antibioticS belonging to the lincosamide family. (J: Anti-infectives), ATC code: J01FF01.</p><p>This medicine is indicated for the treatment of certain severe bacterial infections caused by microorganisms susceptible to this antibiotic.</p><p>This medicine is also indicated for the prevention of infective endocarditis during dental care and upper respiratory tract procedures performed on an outpatient basis in patients allergic to beta lactams (penicillins, cephalosporins).</p><p>Only use this medicine if you have a medical prescription for it (see Advice/Health education).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take DALACIN C capsules:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to clindamycin, lincomycin or any of the other ingredients mentioned in section 6;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in children aged under 6 years since they may choke on the capsule.</p><p>If you are unsure about anything, you must ask your doctor or pharmacist for advice</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Before taking this medicine, tell your doctor if you have:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a history of allergy, particularly to antibiotics, or a history of asthma,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hepatic insufficiency (liver disease).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an intolerance to certain sugars.</p><p>&nbsp;</p><p>Tell your doctor immediately if any of the following disorders occurs during treatment with DALACIN C, capsules:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe and sudden allergic reaction (anaphylactic reaction, Quincke&rsquo;s oedema).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin reaction (DRESS syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis).</p><p>There is a slight risk of severe allergic reaction, with the following symptoms: tightness in the chest, dizzy spells, sudden swelling of the face and neck, severe cutaneous rash. Stop taking DALACIN C, capsules if these symptoms occur, because they are potentially life-threatening, and contact your doctor immediately.</p><p>&nbsp;</p><p>The occurrence early in treatment of redness spreading all over the body with pustules, together with a fever, would suggest a severe reaction known as acute generalized exanthematous pustulosis (see 4. Possible side effects); tell your doctor immediately because it means treatment must be discontinued; after such a reaction any further administration of clindamycin is contraindicated.</p><p>&nbsp;</p><p>You may experience diarrhoea when taking antibiotics, including clindamycin, even several weeks after treatment. Tell your doctor immediately if your diarrhoea becomes severe or persistent, or if you notice blood or mucus in your stools. Clindamycin therapy should be discontinued immediately since the reaction may be life threatening. In that case, do not take any medicine to stop or slow down your intestinal transit.</p><p><strong>&nbsp;</strong></p><p>Acute kidney disorders may occur. Please inform your doctor about any medication you currently take and if you have any existing problems with your kidneys. If you experience decreased urine output, fluid retention causing swelling in your legs, ankles or feet, shortness of breath, or nausea you should contact your doctor immediately.</p><p>Laboratory tests will be carried out if you are prescribed this treatment for a long period.</p><p>&nbsp;</p><p>Due to the risk of oesophageal damage, it is important to comply with the intake conditions of the medicinal product (see &ldquo;Method and route of administration&rdquo;).</p><p>&nbsp;</p><p>Talk to your doctor or pharmacist before taking DALACIN C, capsules.</p><p>&nbsp;</p><p>Children</p><p>Not applicable</p><p>&nbsp;</p><p>Other medicines and DALACIN C capsules</p><p>Your doctor may need to take regular blood tests to check more frequently how well your blood can clot.</p><p>Topical gastrointestinal agents, charcoal and antacids (aluminium, calcium and magnesium salts), reduce the digestive absorption of this medicinal products taken simultaneously. As a precaution, these topical gastrointestinal agents or antacids should be taken 2 hours after any other medicinal product.</p><p>Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a doctor&rsquo;s prescription.</p><p>&nbsp;</p><p>DALACIN C capsules with food, drink and alcohol</p><p>Not applicable.</p><p>&nbsp;</p><p>Pregnancy, breastfeeding and fertility</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><em>Pregnancy</em></p><p>It is preferable as a precaution not to use this medicine during the first trimester of pregnancy. During the second and third trimesters of pregnancy, clindamycin can be used if your doctor decides the treatment is necessary. &nbsp;</p><p>If you discover you are pregnant while taking this medicine, contact your doctor rapidly. Only he/she is competent to decide whether you should continue taking the medicine or not.</p><p><em>Breastfeeding</em></p><p>This medicine is excreted in low concentrations in human breast milk. Breast-feeding is possible whilst taking this medicine. However, in cases of diarrhoea, blood in stools or cutaneous rashes in your child, consult your doctor as soon as possible to review your treatment.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>Driving and using machines</p><p>DALACIN is not expected to have deleterious effects on driving or using machines.</p><p>Not applicable.</p><p>&nbsp;</p><p>DALACIN C capsules contains lactose</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>Posology</p><p>Always take this medicine exactly as your doctor has told you.</p><p>For information, the usual dose is:</p><p><em><u>Treatment of infections</u></em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adults: 600 to 2,400&nbsp;mg/24 hours in 2, 3 or 4 doses.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children aged over 6 years: 8 to 25&nbsp;mg/kg/24 hours in 3 to 4 doses.</p><p><em><u>Prevention of infective endocarditis</u></em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adults: 600&nbsp;mg orally in the hour preceding the procedure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children aged over 6 years: 15&nbsp;mg/kg orally in the hour preceding the procedure.</p><p>&nbsp;</p><p>Method and route of administration</p><p>Oral route.</p><p>Swallow the capsules whole, without crunching them, nor opening them with a large glass of water.</p><p>Capsules must be taken in an upright position (standing or sitting). It is important not to lie down for at least 30 minutes after taking the capsules.</p><p>DALACIN capsules are not for children unable to swallow them whole.</p><p>&nbsp;</p><p>Administration frequency</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><u>Treatment of infections</u></em>: 2, 3 or 4 doses per day.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><u>Preventive treatment</u></em>: 1 dose in the hour preceding the procedure.</p><p>&nbsp;</p><p>Treatment duration</p><p>To be effective, this antibiotic must be taken regularly at the prescribed doses and for as long as the doctor has prescribed it.</p><p>The disappearance of fever or any other symptoms does not mean that you are completely cured.</p><p>Any possible impression of tiredness is not due to treatment with the antibiotic, but to the infection. Reducing or discontinuing treatment would have no effect on the impression and would delay your recovery.</p><p>&nbsp;</p><p>If you have taken more DALACIN C capsules than you should</p><p>Immediately contact your doctor or pharmacist.</p><p>If you forgot to take DALACIN C capsules</p><p>Treatment must be continued normally, leaving out the missing dose.</p><p>If you stop taking DALACIN C capsules</p><p>Not applicable.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can have side effects, although not everybody gets them.</p><p>Tell your doctor immediately if you develop:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid retention causing swelling in your legs, ankles or feet, shortness of breath or nausea.</p><p>The frequency of the possible side effects listed below has been defined based on the following conventions:</p><p><em>Very common</em> (affecting more than one in 10 patients)</p><p><em>Common</em> (affecting between 1 and 10 in 100 patients)</p><p><em>Uncommon</em> (affecting between 1 and 10 in 1,000 patients)</p><p><em>Rare</em> (affecting between 1 and 10 in 10,000 patients)</p><p><em>Very rare</em> (affecting fewer than 1 in 10,000 patients)</p><p>&nbsp;</p><p>Common side effects:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the intestines when used with antibiotics (pseudomembranous colitis),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea, stomach pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Modifications of hepatic tests (of the liver),</p><p>&nbsp;</p><p>Uncommon side effects:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea, vomiting,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rashes that can take the form of papules and macules.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urticaria.</p><p>&nbsp;</p><p>Side effects with unknown frequency:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug-induced hypersensitivity reactions (severe, unpredictable allergic reaction caused by a medicine) including Quincke&#39;s oedema (sudden swelling of the face and neck) observed in patients who are allergic to penicillin,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe cutaneous effects that may be fatal such as:</p><p>o&nbsp;&nbsp; blisters and bubbles on the body, particularly around the mouth, nose, eyes and in the genital area (Lyell&#39;s and Stevens-Johnson syndromes),</p><p>o&nbsp;&nbsp; skin rash that may be associated with fever, occurring suddenly and starting on the face or skin folds and that can get generalised (acute generalised exanthematous pustulosis),</p><p>o&nbsp;&nbsp; or severe allergic reaction (drug hypersensitivity syndrome also called DRESS syndrome) possibly associating several symptoms such as fever, skin rash, increase in nodes size, serious fatigue, liver or kidney lesions and abnormal blood test results such as an increased number of certain white blood cells (eosinophilia),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Redness of the skin (erythema), itching (pruritus), other cutaneous lesions (dermatitis exfoliative, dermatitis bullous, erythema multiform).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insufficient quantity of certain components of the blood (white blood cells, platelets), that may cause unexplained fever or small reddish-purplish spots on the skin (thrombocytopenic purpura),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in certain white blood cells (eosinophilia),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Altered taste (dysgeusia),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the mucous membranes of the oesophagus (oesophagitis and oesophageal ulcer),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellow colouration of the skin, mucous membranes and white of the eye (jaundice),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infection of the vagina,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colitis associated with a <em>Clostridium difficile </em>infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Musculoskeletal</strong><strong>:</strong> Rare instances cases of polyarthritis have been reported with the oral or parenteral use of clindamycin</p><p>&nbsp;</p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:378px"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Center (NPC)</strong></p><p>Call center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website :https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the outer packaging.</p><p>Store below 25&deg;C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DALACIN C 150 mg, capsules</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is:</p><p>Clindamycin base ................................................................................................................... 150.00&nbsp;mg</p><p>In the form of hydrated clindamycin hydrochloride</p><p>For one capsule.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are:</p><p>Maize Starch, Talc, Magnesium Stearate, and Lactose Monohydrate.</p><p>&nbsp;</p><p>DALACIN C 300 mg, capsules</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is:</p><p>Clindamycin base........................................................................... 300 mg</p><p>In the form of hydrated clindamycin hydrochloride</p><p>For one capsule.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are:</p><p>Maize Starch, Talc, Magnesium Stearate, and Lactose Monohydrate.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The medicine is commercialised as capsules. 
Dalacin C 150mg: Box of 16 capsules in blister packs (Aluminium foil/PVC).
Dalacin C 300mg: Box of 16 capsules in blister packs (Aluminium foil/PVC).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing authorisation holder </strong></p><p>Pfizer Holding France 23-25,</p><p>Avenue Du Docteur lannelongue&nbsp;</p><p>75014 Paris France&nbsp;</p><p>&nbsp;</p><p>Manufacturer</p><p>Fareva Amboise</p><p>Zone Industrielle</p><p>29 Route Des Industries</p><p>37530 Poce-Sur- Cisse&nbsp;</p><p>France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                March 2024.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">المجموعة&nbsp; الدوائية العلاجية: مضاد حيوي مضاد للبكتيريا ينتمي إلى عائلة اللينكوساميدات.</p><p dir="RTL">(J: مضادات العدوى) ، رمز نظام التصنيف الكميائي العلاجي التشريحي (ATC): J01FF01.</p><p dir="RTL">يوصف هذا الدواء لعلاج بعض العداوى البكتيرية الحادة التي تسببها كائنات دقيقة حساسة تجاه هذا المضاد الحيوي.</p><p dir="RTL">كما يوصف هذا الدواء للوقاية من الإصابة بالتهاب بطانة وصمامات القلب أثناء علاج الأسنان و أثناء الإجراءات الخاصة بالجهاز التنفسي العلوي التي تتم للمرضى الخارجيين الذين يعانون من الحساسية تجاهالمضادات الحيوية التى تنتمى لعائلة بيتا لاكتام (مشتقات البنسلين، السيفالوسبورينات).</p><p dir="RTL">لا تستخدم هذا الدواء إلا إذا كانت لديك وصفة طبية (<u>انظر نصائح/التثقيف الصحي</u>).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>موانع استعمال دالاسين سي:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه الكليندامايسين أو اللينكومايسين أو أي مكون آخر من المكونات المدرجة في القسم ٦؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .في الأطفال أقل من ٦ أعوام حيث قد تعرضهم الكبسولات للاختناق</p><p dir="RTL">إذا كنت غير متأكد بشأن أي شيء، يجب عليك استشارة طبيبك أو الصيدلي</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال دالاسين سي</strong></p><p dir="RTL">:قبل تناول هذا الدواء، أخبر طبيبك إذا</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك تاريخ من الإصابة بالحساسية، خاصةً تجاه المضادات الحيوية، أو تاريخ من ،الإصابة بالربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;كنت تعاني من قصور بوظائف الكبد (مرض بالكبد).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .كنت تعاني من عدم تحمل بعض السكريات</p><p dir="RTL">&nbsp;</p><p dir="RTL">:أخبر طبيبك فورًا إذا حدثت أي من الاضطرابات التالية أثناء العلاج بكبسولات دالاسين سي</p><p dir="RTL">&nbsp;</p><p dir="RTL">حساسية حادة و مفاجئة&nbsp; (تفاعل تأقي، وذمة كوينكه).</p><p dir="RTL">تفاعل حساسية شديد في الجلد (متلازمة التفاعلات الدوائية المصحوبة بكثرة اليوزينيات وأعراض جهازية (DRESS)، متلازمة ستيفنز-جونسون، تقشر الأنسجة المتموتة البشروية التسممي).</p><p dir="RTL">يوجد خطر بسيط للإصابة&nbsp; بحساسية حادة و مفاجئة ، مصحوب بالأعراض التالية: ضيق بالصدر، نوبات دوار، تورم الوجه والعنق المفاجئ، آثار جلدية شديدة. توقف عن تناول كبسولات دالاسين سي إذا ظهرت هذه الأعراض، حيث أنها قد تكون مهددة للحياة، واتصل بطبيبك فورًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يشير ظهور احمرار بالجسم مصحوب ببثور وحُمَّى في بداية العلاج تنتشر في أنحاء الجسم إلى تفاعل حاد يُعرف باسم البثار الطفحي المعمم الحاد (انظر ٤. الأعراض الجانبية)؛ أخبر طبيبك فورًا حيث يعني ذلك ضرورة إيقاف العلاج؛ وبعد حدوث مثل هذا التفاعل، يحظر أي استعمال للكليندامايسين بعد ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تصاب بالإسهال عند تناول المضادات الحيوية، بما في ذلك الكليندامايسين، حتى وإن كان بعد عدة أسابيع من العلاج. أخبر طبيبك فورًا إذا أصبح الإسهال حادًا أو مستمرًا، أو إذا لاحظت دمًا أو مخاطًا ببرازك. يجب إيقاف العلاج بالكليندامايسين فورًا لأن هذا التفاعل قد يكون مُهددًا للحياة. في هذة الحالة،&nbsp; لا تتناول أي دواء لإيقاف أو إبطاء حركة الأمعاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تحدث اضطرابات كلوية حادة. يُرجى إبلاغ طبيبك عن أي دواء تتناوله حاليًا وإذا كنت تعاني من أي مشكلات في كليتيك. إذا كنت تعاني من انخفاض في كمية البول، أو احتباس السوائل الذي يسبب تورمًا في ساقيك، أو كاحليك أو قدميك، أو ضيق في التنفس، أو غثيان، ينبغي لك الاتصال بطبيبك على الفور.</p><p dir="RTL">سيتم إجراء اختبارات معملية في حالة وصف هذا الدواء لك لفترة طويلة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لخطر الإصابة بتلف المريء، من المهم الالتزام بشروط تناول المنتج الطبي (انظر &quot;طريقة وسبيل التناول&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدّث مع طبيبك أو الصيدلي قبل تناول كبسولات دالاسين سي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا ينطبق</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">قد يحتاج طبيبك إلى إجراء فحوصات دم منتظمة لك للتحقق من&nbsp; نسبة تجلط الدم لديك&nbsp; بصفة أكثر استمرارا.</p><p dir="RTL">تقلل الادوية المعدية المعوية الموضعية والفحم ومضادات الحموضة (أملاح الألومنيوم والكالسيوم والمغنسيوم)، من الامتصاص الهضمي&nbsp; للمنتجات الدوائية التي يتم تناولهما في نفس الوقت. ينبغي تناول الادويه المعدية المعوية الموضعية أو مضادات الحموضة بعد أي منتج دوائي آخر بساعتين كإجراء وقائي.</p><p dir="RTL">يُرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، بما فى ذلك الادوية التي تم الحصول عليها بدون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول دالاسين سي مع الطعام والشراب</strong></p><p dir="RTL">.لا ينطبق</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل</strong><strong> والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبكِ أو الصيدلي قبل تناول هذا الدواء</p><p dir="RTL">الحمل</p><p dir="RTL">يُفضل كإجراء احترازي عدم استعمال هذا الدواء أثناء الثلث الأول من الحمل. يمكن استخدام كليندامايسين خلال الثلثين الثاني والثالث من الحمل إذا قرر طبيبك أن العلاج به .ضروري</p><p dir="RTL"><em>الرضاعة الطبيعية</em></p><p dir="RTL">يُفرز هذا الدواء بتركيزات قليلة في لبن ثدي الأم في البشر. الرضاعة الطبيعية ممكنة أثناء تناول هذا الدواء، ولكن في حالات الإصابة بالإسهال أو وجود دم في البراز أو الطفح الجلدي لدى طفلكِ، استشيري طبيبكِ في أقرب وقت ممكن لمراجعة علاجكِ.</p><p dir="RTL">اطلبي المشورة من طبيبكِ أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير دالاسين سي على القيادة واستخدام الآلات</strong></p><p dir="RTL">يتوقع أن يكون لدالاسين سي أي آثار ضارة على قيادة السيارت أو&nbsp; استعمال&nbsp; الآلات.</p><p dir="RTL">لا ينطبق.</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات دالاسين سي</strong></p><p dir="RTL"><strong>تحتوي كبسولات &nbsp;دالاسين سي</strong> <strong>على اللاكتوز</strong></p><p dir="RTL">إذا أعلمك طبيبك بعدم تحملك لبعض أنواع السكر، فتواصل مع طبيبك قبل تناول هذا المنتج الدوائي.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">استخدم دائمًا هذا الدواء تماما كما اخبرك طبيبك او الصيدلي تحقق من طبيبك او الصيدلي .اذا لم تكن متأكدًا</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>الجرعة</u></strong><br />تناول دائمًا هذا الدواء تمامًا كما أخبرك طبيبك</p><p dir="RTL">:لمعلوماتك، الجرعة المعتادة هي</p><p dir="RTL"><u>علاج العدوى</u></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البالغون: من ٦٠٠ إلى ۲٤٠٠ ملجم/۲٤ ساعة مُقسمة على جرعتين أو ثلاث أو أربع جرعات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأطفال أكبر من ٦ أعوام: من ٨ إلى ۲٥ ملجم/كجم/۲٤ ساعة مُقسمة على ثلاث أو أربع جرعات.</p><p dir="RTL"><em><u>الوقاية من التهاب</u></em> بطانة و صمامت القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البالغون: ٦٠٠ ملجم عن طريق الفم خلال الساعة السابقة للإجراء.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأطفال أكبر من ٦ أعوام: ۱٥ ملجم/كجم عن طريق الفم خلال الساعة السابقة للإجراء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>طريقة وسبيل</u></strong><strong><u> التناول</u></strong><strong><u> </u></strong></p><p dir="RTL">التناول عن طريق الفم .</p><p dir="RTL">.قم بابتلاع الكبسولات بالكامل من دون طحنها أو فتحها مع شرب كوب كبير من الماء</p><p dir="RTL">يجب تناول الكبسولات في وضع مستقيم (الوقوف أو الجلوس). ومن المهم عدم الاستلقاء لمدة ۳۰ دقيقة على الأقل بعد تناول الكبسولات.</p><p dir="RTL">.كبسولات دالاسين سي غير مخصصة للأطفال الذين لا يستطيعون ابتلاعها كاملة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>معدل تكرار تناول الدواء</u></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>.علاج العدوى:</u> جرعتين أو ثلاث أو أربع جرعات في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>.العلاج الوقائي:</u> جرعة واحدة خلال الساعة السابقة للإجراء</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>مدة العلاج</u></strong></p><p dir="RTL">يجب تناول هذا المضاد الحيوي بانتظام وبالجرعات الموصوفة وطوال المدة التي وصفها .لك الطبيب حتى يكون فعالًا</p><p dir="RTL">.لا يعني اختفاء الحُمى أو أي من الأعراض الأخرى أنك شُفيت تمامًا</p><p dir="RTL">إن أي شعور محتمل بالتعب ليس نتيجة للعلاج بالمضاد الحيوي، بل نتيجة للعدوى. لن يكون .لتقليل أو إيقاف العلاج أي تأثير على هذا الشعور بل قد يؤخر شفائك</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من دالاسين سي:</strong></p><p dir="RTL">اتصل بطبيبك أو الصيدلي فورًا..</p><p dir="RTL"><strong>نسيان تناول جرعة دالاسين سي:</strong></p><p dir="RTL">.يجب استكمال العلاج بصورة طبيعية، مع تفويت الجرعة المنسية</p><p dir="RTL"><strong>التوقف عن تناول دالاسين سي</strong></p><p dir="RTL">لا ينطبق.</p><p dir="RTL">إذا كانت لديك أي أسئلة أخرى حول استخدام هذا الدواء، فاطرحها على طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال دالاسين سي:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه الكليندامايسين أو اللينكومايسين أو أي مكون آخر من المكونات المدرجة في القسم ٦؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الأطفال أقل من ٦ أعوام حيث قد تعرضهم الكبسولات للاختناق.</p><p dir="RTL">إذا كنت غير متأكد بشأن أي شيء، يجب عليك استشارة طبيبك أو الصيدلي</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال دالاسين سي</strong></p><p dir="RTL">قبل تناول هذا الدواء، أخبر طبيبك إذا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك تاريخ من الإصابة بالحساسية، خاصةً تجاه المضادات الحيوية، أو تاريخ من الإصابة بالربو،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من قصور بوظائف الكبد (مرض بالكبد).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من عدم تحمل بعض السكريات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك فورًا إذا حدثت أي من الاضطرابات التالية أثناء العلاج بكبسولات دالاسين سي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">حساسية حادة و مفاجئة&nbsp; (تفاعل تأقي، وذمة كوينكه).</p><p dir="RTL"><strong>تفاعل حساسية شديد في الجلد (متلازمة التفاعلات الدوائية المصحوبة بكثرة اليوزينيات وأعراض جهازية </strong><strong>(</strong>DRESS<strong>)</strong><strong>، متلازمة ستيفنز-جونسون، تقشر الأنسجة المتموتة البشروية التسممي).</strong></p><p dir="RTL">يوجد خطر بسيط للإصابة &nbsp;بحساسية حادة و مفاجئة ، مصحوب بالأعراض التالية: ضيق بالصدر، نوبات دوار، تورم الوجه والعنق المفاجئ، آثار جلدية شديدة. توقف عن تناول كبسولات دالاسين سي إذا ظهرت هذه الأعراض، حيث أنها قد تكون مهددة للحياة، واتصل بطبيبك فورًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يشير ظهور احمرار بالجسم مصحوب ببثور وحُمَّى في بداية العلاج تنتشر في أنحاء الجسم إلى تفاعل حاد يُعرف باسم البثار الطفحي المعمم الحاد (انظر ٤. الأعراض الجانبية)؛ أخبر طبيبك فورًا حيث يعني ذلك ضرورة إيقاف العلاج؛ وبعد حدوث مثل هذا التفاعل، يحظر أي استعمال للكليندامايسين بعد ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تصاب بالإسهال عند تناول المضادات الحيوية، بما في ذلك الكليندامايسين، حتى وإن كان بعد عدة أسابيع من العلاج. أخبر طبيبك فورًا إذا أصبح الإسهال حادًا أو مستمرًا، أو إذا لاحظت دمًا أو مخاطًا ببرازك. يجب إيقاف العلاج بالكليندامايسين فورًا لأن هذا التفاعل قد يكون مُهددًا للحياة. في هذة الحالة،&nbsp; لا تتناول أي دواء لإيقاف أو إبطاء حركة الأمعاء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>قد تحدث اضطرابات </strong><strong>كلوية </strong><strong>حادة. ي</strong><strong>ُ</strong><strong>رجى إبلاغ طبيبك عن أي دواء تتناوله حاليًا وإذا ك</strong><strong>نت تعاني من </strong><strong>أي </strong><strong>مشكلات</strong><strong> </strong><strong>في</strong><strong> كليتيك. إذا كنت تعاني من انخفاض في كمية البول، أو احتباس ال</strong><strong>سوائل الذي يسبب تورمًا في ساقيك، أو كاحليك أو قدميك، أو ضيق في التنفس، أو غثيان</strong><strong>، </strong><strong>ينبغي لك </strong><strong>الاتصال بطبيبك على الفور</strong><strong>.</strong></p><p dir="RTL">سيتم إجراء اختبارات معملية في حالة وصف هذا الدواء لك لفترة طويلة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدّث مع طبيبك أو الصيدلي قبل تناول كبسولات دالاسين سي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا ينطبق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">قد يحتاج طبيبك إلى إجراء فحوصات دم منتظمة لك للتحقق من &nbsp;نسبة تجلط الدم لديك &nbsp;بصفة أكثر استمرارا.</p><p dir="RTL">تقلل الادوية المعدية المعوية الموضعية والفحم ومضادات الحموضة (أملاح الألومنيوم والكالسيوم والمغنسيوم)، من الامتصاص الهضمي&nbsp; للمنتجات الدوائية التي يتم تناولهما في نفس الوقت. ينبغي تناول الادويه المعدية المعوية الموضعية أو مضادات الحموضة بعد أي منتج دوائي آخر بساعتين كإجراء وقائي.</p><p dir="RTL">يُرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، بما فى ذلك الادوية التي تم الحصول عليها بدون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول دالاسين سي مع الطعام والشراب</strong></p><p dir="RTL">لا ينطبق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل و</strong><strong>الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبكِ أو الصيدلي قبل تناول هذا الدواء</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL">&nbsp;</p><p dir="RTL">يُفضل كإجراء احترازي عدم <strong>استعمال</strong> هذا الدواء أثناء الثلث الأول من الحمل. يمكن استخدام كليندامايسين خلال الثلثين الثاني والثالث من الحمل إذا قرر طبيبك أن العلاج به ضروري.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الرضاعة الطبيعية</em></p><p dir="RTL">يُفرز هذا الدواء بتركيزات قليلة في لبن ثدي الأم في البشر. الرضاعة الطبيعية ممكنة أثناء تناول هذا الدواء، ولكن في حالات الإصابة بالإسهال أو وجود دم في البراز أو الطفح الجلدي لدى طفلكِ، استشيري طبيبكِ في أقرب وقت ممكن لمراجعة علاجكِ.</p><p dir="RTL">اطلبي المشورة من طبيبكِ أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير دالاسين سي على القيادة واستخدام الآلات</strong></p><p dir="RTL">يتوقع أن يكون لدالاسين سي أي آثار ضارة على قيادة السيارت أو&nbsp; استعمال&nbsp; الآلات.</p><p dir="RTL">لا ينطبق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحتوي كبسولات &nbsp;دالاسين سي</strong> <strong>على اللاكتوز</strong></p><p dir="RTL">إذا أعلمك طبيبك بعدم تحملك لبعض أنواع السكر، فتواصل مع طبيبك قبل تناول هذا المنتج الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">يحفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العبوة الخارجية.</p><p dir="RTL">&nbsp;يتم التخزين في درجة حرارة اقل من ۲٥ درجة مئوية.</p><p dir="RTL">ألا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه التدابير على حماية البيئة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>كبسولات دالاسين سي </strong><strong>۱</strong><strong>٥</strong><strong>٠</strong><strong> ملجم</strong></p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>المادة الفعالة هي:</p><p dir="RTL">قاعدة الكلينداميسين ............................................................... ۱٥٠ ملجم في صورة هيدروكلوريد الكلينداميسين المميه</p><p dir="RTL">&nbsp;للكبسولة الواحدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي:</p><p dir="RTL">نشا الذرة، تلك، ستيارات المغنيسيوم، لاكتوز مونوهيدرات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>كبسولات دالاسين سي ٣٠٠ ملجم</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي:</p><p dir="RTL">قاعدة الكليندامايسين.....................................................................................&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ٣٠٠ ملجم في صورة هيدروكلوريد الكلينداميسين المميه</p><p dir="RTL">للكبسولة الواحدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي:</p><p dir="RTL">.نشا الذرة، تلك، ستيارات المغنيسيوم، لاكتوز مونوهيدرات</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">يتم تسويق هذا الدواء في صورة كبسولات.</p><p dir="RTL">دالاسين سي ۱٥٠ ملجم: عبوة بها ۱٦كبسولة في عبوات بليستر (رقائق الألومنيوم/كلوريد البولي فينيل).</p><p dir="RTL">دالاسين سي ٣٠٠ ملجم: عبوة بها ۱٦ كبسولة في عبوات بليستر (رقائق الألومنيوم/كلوريد البولي فينيل).</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك رخصة التسويق</p><p dir="RTL">Pfizer Holding France</p><p dir="RTL">23-25, Avenue Du Docteur lannelongue</p><p dir="RTL">75014 Paris France</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المصنعة</strong></p><p dir="RTL">&nbsp;Fareva Amboise</p><p dir="RTL">Zone Industrielle</p><p dir="RTL">29 Route Des Industries</p><p dir="RTL">37530 Poce-Sur_Cisse</p><p dir="RTL">France</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مارس/آذار ۲۰۲٤.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DALACIN C 150 mg, capsules
DALACIN C 300 mg, capsules

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                For one 150 mg Capsule:

Clindamycin base	150.00 mg
Quantity corresponding to Clindamycin hydrochloride, hydrated

For one 300 mg Capsule:

Clindamycin base	300.00 mg
Quantity corresponding to Clindamycin hydrochloride, hydrated

Excipient with known effect: lactose
For the full list of excipients, see section 6.1. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsule.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>They derive from the antibacterial and pharmacokinetic characteristics of clindamycin. They are based on data obtained from clinical studies performed with the medicinal product and its place in the range of currently available antibacterial products.</p><p>&nbsp;</p><p>Treatment of infections:</p><p>Clindamycin is indicated for the treatment of severe infections by susceptible micro-organisms causing namely:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ears, nose and throat infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bronchopulmonary infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomatological infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; genital infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; osteoarticular infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; post-surgical abdominal infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; septicaemia.</p><p>Except for meningeal infections even if caused by susceptible micro-organisms, because the antibiotic does not diffuse into CSF in therapeutically effective quantities.</p><p>&nbsp;</p><p>Prophylaxis:</p><p>Prophylaxis of infective endocarditis during dental care and upper respiratory tract procedures performed on an outpatient basis in patients allergic to beta lactams.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>Treatment of infections:</p><p>Adults: 600 to 2,400&nbsp;mg/24 hours in 2, 3 or 4 doses.</p><p>Prophylaxis:</p><p>Adults: 600&nbsp;mg orally in the hour preceding the procedure.</p><p><em>Paediatric population</em>DALACIN capsules are not suitable for children, who are unable to swallow them whole.</p><p>Use of the capsules may not be appropriate to provide the exact doses required in mg/kg to treat children.</p><p>Clindamycin posology in children should be adapted based on total body weight, regardless of an obesity.</p><p><strong>Treatment of infections:</strong></p><p>Children aged over 6 years: 8 to 25&nbsp;mg/kg/24&nbsp;hours, in 3 to 4 doses.</p><p><strong>Prophylaxis:</strong></p><p>Children aged over 6 years: 15&nbsp;mg/kg orally in the hour preceding the procedure.</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Method of administration</u></strong></p><p>Capsules must be taken whole, swallowed with a large glass of water. They must be taken in an upright position (standing or sitting), without lying down for at least 30 minutes after administration.</p><p>Clindamycin absorption is not significantly modified by concomitant food intake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicinal product must never be used:
•	in cases of hypersensitivity to the active substance, to lincomycin or to any excipients listed in section 6.1,
•	in children aged under 6 years, because of the pharmaceutical form,
•	in breast-feeding women (see section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Antibiotic-associated colitis</u></em></p><p>Pseudomembranous colitis and antibiotic-associated colitis have been observed with use of nearly all antibacterial agents including clindamycin (see section 4.8); they may range in severity from mild to life-threatening. Consequently, it is important to consider this diagnosis in the event of diarrhoea occurring during or after the administration of any antibiotic. If an antibiotic-associated colitis arises, clindamycin must be discontinued immediately; a doctor should be consulted and adequate treatment, including a specific treatment against Clostridium difficile should be initiated. Drugs inhibiting peristalsis are contraindicated in this situation.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Hypersensitivity</u></em></p><p>Severe hypersensitivity reactions, including severe skin reactions such as drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP) have been reported in patients receiving clindamycin treatment. In cases of hypersensitivity or severe skin reaction occurs, clindamycin should be discontinued and appropriate medical treatment should be initiated (see sections 4.3 and 4.8).</p><p>Clindamycin should be used with caution in patients with a history of asthma or other allergies.</p><p>The occurrence early in treatment of generalised erythema with pyrexia and pustules would suggest acute generalised exanthematous pustulosis (see section 4.8); treatment must be discontinued and any further administration of clindamycin is contraindicated.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Hepatic insufficiency</u></em></p><p>Raised clindamycin serum levels and increased elimination half-life have been reported in cases of hepatic insufficiency.</p><p>If therapy is prolonged, liver and kidney functions tests should be performed.</p><p><em><u>&nbsp;</u></em></p><p><em><u>Acute kidney injury&nbsp; </u></em></p><p>Acute kidney injury, including acute renal failure, has been reported infrequently. In patients receiving prolonged therapy, suffering from pre-existing renal dysfunction or taking concomitant nephrotoxic drugs, monitoring of renal function should be considered (see section 4.8).</p><p><em><u>&nbsp;</u></em></p><p><em><u>Long-term treatment</u></em></p><p>Long-term treatment should only be undertaken with close monitoring of blood counts, liver enzymes and renal function.</p><p>Antibiotic use, particularly for long periods, is associated with the emergence and selection of less susceptible bacteria or the development of fungi. Appropriate treatment must be initiated in the event of superinfection.</p><p>This drug must not be used in the treatment of meningitis since clindamycin does not diffuse adequately into cerebrospinal fluid (see section 4.1).</p><p><em><u>&nbsp;</u></em></p><p><em><u>Oesophageal damage</u></em></p><p>Due to the risk of oesophageal damage, it is important to ensure compliance with administration conditions (see Sections 4.2 and 4.8).</p><p>&nbsp;</p><p><em><u>Excipients</u></em></p><p>This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations requiring precautions for use</p><p>+ Vitamin K antagonists:</p><p>Increased antivitamin K effect and/or bleeding,</p><p>More frequent INR monitoring. If necessary dose adjustment of antivitamin K during treatment with clindamycin and after treatment discontinuation.</p><p>+ Topical gastrointestinal agents, antacids and adsorbents</p><p>Topical gastrointestinal agents, charcoal and antacids (aluminium, calcium and magnesium salts), alone or combined with alginates, reduce the digestive absorption of certain other medicinal products taken simultaneously. Medicinal products for which a reduction in gastrointestinal absorption has been observed include acetylsalicylic acid, H2 blockers and lansoprazole, bisphosphonates, catioresins, certain classes of antibiotics (fluoroquinolones, tetracyclines, lincosamides) and some anti-tubercular agents, digitalis, glucocorticoids, thyroid hormones, phenothiazine neuroleptics, sulpiride, certain beta-blockers, penicillamine, ions (iron, phosphorus, fluorine), chloroquine, ulipristal and fexofenadine.</p><p>As a precaution, these topical gastrointestinal agents or antacids should be taken some time apart from any other medicinal product (more than 2 hours, if possible).</p><p>+ Ciclosporin</p><p>Decrease in the blood concentrations of the immunosuppressive agent, associated with a risk of loss of immunosuppressive activity. Increase monitoring of ciclosporin blood levels and increase its dosage if required.</p><p>+ Cytochrome P450 (CYP) 3A4 inducers</p><p>Clindamycin is mainly metabolised by CYP3A4, and to a lesser extent by CYP3A5, to form the major metabolite, clindamycin sulphoxide, and the minor metabolite, N-desmethylclindamycin. Therefore, CYP3A4 and CYP3A5 inhibitors may reduce clindamycin clearance, and the inducers of these isoenzymes may increase clindamycin clearance. In the presence of potent CYP3A4 inducers such as rifampicin, monitoring of loss of efficacy is required.</p><p><em>In vitro</em> studies indicate that clindamycin does not inhibit CYP1A2, CYP2C9, CYP2C19, CYP2E1 or CYP2D6, and only moderately inhibits CYP3A4. Therefore, clinically significant interactions between clindamycin and coadministered medicinal products metabolised by these cytochromes are unlikely.</p><p>+ Tacrolimus</p><p>Decrease in the blood concentrations of the immunosuppressive agent, associated with a risk of loss of immunosuppressive activity. Increase monitoring of tacrolimus blood levels and increase its dosage if required.</p><p>&nbsp;</p><p>Specific problems related to changes in the INR</p><p>Several cases of increases in the activity of antivitamin K have been reported in patients receiving antibiotics. Risk factors include the degree of severity of infection or inflammation and the patient&rsquo;s age and general condition. In such cases, it is difficult to discern whether the infection or the treatment is responsible for the change in INR. However, certain classes of antibiotics are more implicated than others, namely fluoroquinolones, macrolides, cyclins, <em>cotrimoxazole</em> and certain cephalosporins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>In embryo-foetal development studies (see section 5.3) no toxicity was observed on the development except at doses that caused toxicity in the mother.</p><p>Clindamycin crosses the placenta.</p><p>Exposure data of clindamycin by systematic or topical route in pregnant woman during the first trimester are limited.</p><p>Available data of exposure during the second and third trimesters, are numerous and an increased foetal risk has not been reported.</p><p>Thus, taken into account the available data, it is preferable as a precaution not to use clindamycin during the first trimester of pregnancy.</p><p>During the second and third trimesters of pregnancy, clindamycin can be used if necessary.</p><p>&nbsp;</p><p>Breast-feeding</p><p>The excretion of clindamycin in human breast milk is low and the quantities ingested are much lower than paediatric therapeutic doses after systemic use.</p><p>Therefore, breast-feeding is possible whilst taking this antibiotic. However, in cases of diarrhoea, blood in stools, candidiasis or cutaneous rash in the infant, the continuation of breast-feeding (or off taking the medicine) must be reviewed.</p><p>&nbsp;</p><p>Fertility</p><p>Fertility studies in rats treated with clindamycin revealed no effects on fertility or mating ability.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>DALACIN has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below lists the adverse reactions identified through clinical trial experience and post-marketing surveillance by system organ class and frequency.&nbsp;</p><p>Following the organ classification system, the adverse reactions are listed below in order of decreasing frequency and then of clinical severity using the following convention: Very common (&ge; 1/10); Common (&ge; 1/100 to &lt; 1/10); Uncommon (&ge; 1/1,000 to &lt; 1/100); Rare (&ge; 1/10,000 to &lt; 1/1,000); Very Rare (&lt; 1/10,000); and Frequency not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td style="vertical-align:top"><p>System Organ</p><p>Class</p></td><td style="vertical-align:top"><p>Common &ge; 1/100 to &lt;1/10</p></td><td style="vertical-align:top"><p>Uncommon &ge; 1/1,000</p><p>to &lt; 1/100</p></td><td style="vertical-align:top"><p>Rare</p><p>&ge; 1/10,000 to &lt; 1/1 000</p></td><td style="vertical-align:top"><p>Very Rare</p><p>&lt; 1/10,000</p></td><td style="vertical-align:top"><p>Frequency not Known</p><p>(cannot be estimated from the available data)</p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Pseudomembranous colitis<sup>*#</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><em>Clostridium difficile colitis<sup>#</sup>, </em>Vaginal infection<em><sup>#</sup></em></p></td></tr><tr><td style="vertical-align:top"><p>Blood and Lymphatic System Disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Agranulocytosis<em><sup>#</sup></em>, Neutropenia<em><sup>#</sup></em>, Thrombocytopenia*, Leukopenia<em><sup>#</sup></em>, Eosinophilia, Thrombocytopenic purpura</p></td></tr><tr><td style="vertical-align:top"><p>Immune System Disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic shock<em><sup>#</sup></em>, Anaphylactic reaction<em><sup>#</sup></em>, Hypersensitivity reactions such as Quincke&#39;s oedema and anaphylaxis in some patients allergic to penicillin<em><sup>#</sup></em></p></td></tr><tr><td style="vertical-align:top"><p>Nervous System Disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dysgeusia</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Diarrhoea,</p><p>Adbominal pain</p></td><td style="vertical-align:top"><p>Vomiting,</p><p>Nausea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Oesophageal ulcer<em><sup>#,</sup></em><sup>&sect;</sup>,</p><p>Oesophagitis<em><sup>#,</sup></em><sup>&sect;</sup></p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary Disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Jaundice<em><sup>#</sup></em></p></td></tr><tr><td style="vertical-align:top"><p>Skin and Subcutaneous Tissue Disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Maculo-papular rash</p><p>Urticaria</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Toxic epidermal necrolysis (Lyell syndrome)<sup>#</sup>, Stevens-Johnson syndrome (SJS)<sup>#</sup>,&nbsp; DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome<sup>#</sup>, Acute generalised exanthematous pustulosis (AGEP)<sup>#</sup>, Angio-oedema<sup>#</sup>, Exfoliative dermatitis<sup>#</sup>, Bullous dermatosis<sup>#</sup>, Erythema multiforme, Pruritus, Morbilliform rash <sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Acute kidney injury*</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cases of polyarthritis have been reported</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Liver function test abnormal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>* see section 4.4</p><p><sup># </sup>post-marketing data</p><p><sup>&sect; </sup>Possible occurrence of esophagitis and esophageal ulceration, particularly favored by intake in a lying position and/or with a small amount of water.</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after <u>marketing</u> authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions <u>according to their local country requirements</u>.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Center (NPC)</strong></p><p>Call center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website :https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Haemodialysis and peritoneal dialysis are not effective in removing clindamycin from the serum.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic class: lincosamides, ATC code: <strong>J01FF01.</strong></p><p>Clindamycin is an antibiotic from the lincosamide family.</p><p><u>&nbsp;</u></p><p><u>Mechanism of action</u></p><p>Clindamycin inhibits the synthesis of bacterial proteins by bonding to the 50S sub-unit of the bacterial ribosome. At normal doses, clindamycin has a bacteriostatic activity <em>in vitro</em>.</p><p><u>&nbsp;</u></p><p><u>Pharmacokinetic-pharmacodynamic relationship</u></p><p>The percentage of time during which the concentration of the antibiotic is above the minimum inhibitory concentration (MIC) of the bacteria between two administrations (%T&gt;MIC) is the most predictive parameter for the efficacy of clindamycin.</p><p><u>&nbsp;</u></p><p><u>Resistance</u></p><p>Clindamycin resistance is most often caused by mutations of the site where the antibiotic bonds to the rRNA or methylation of 23S RNA specific nucleotides of the 50S ribosome sub-unit. These changes can determine <em>in vitro</em> cross-resistance to macrolides and B streptogramins (MLS<sub>B</sub> phenotype).</p><p>Resistance mechanisms can also be due to active efflux.</p><p>Clindamycin resistance can be induced by macrolides in macrolide-resistant bacteria strains.</p><p>Full cross-resistance between clindamycin and lincomycin is possible.</p><p>The incidence of clindamycin resistance is higher among methicillin-resistant staphylococcus strains and penicillin-resistant pneumococcal strains.</p><p>&nbsp;</p><p>Critical concentrations</p><p>According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), critical concentrations for clindamycin that separate susceptible strains (S) from resistant strains (R) are as follows:</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p><strong>Critical concentrations of MIC (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Pathogen</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus </em>spp<em>.</em></p></td><td style="vertical-align:top"><p>S &le; 0.25 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus</em></p><p>Groups A, B, C and G</p></td><td style="vertical-align:top"><p>S &le; 0.5 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p>S &le; 0.5 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Streptococci from <em>Viridans </em>group</p></td><td style="vertical-align:top"><p>S &le; 0.5 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Gram-positive anaerobes apart from <em>Clostridium difficile</em></p></td><td style="vertical-align:top"><p>S &le; 4 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 4 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Gram-negative anaerobes</p></td><td style="vertical-align:top"><p>S &le; 4 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 4 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Corynebacterium </em>spp<em>.</em></p></td><td style="vertical-align:top"><p>S &le; 0.5 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Antibacterial spectrum of activity</u></p><p>The prevalence of acquired resistance may vary geographically and with time for certain species. Therefore, local information on the prevalence of resistance is useful, particularly for severe infections. If required, it is desirable to have a specialist opinion, mainly when the benefit of some medicinal products for certain infections can be questioned due to the level of prevalence of local resistance.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Classes</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>NORMALLY SUSCEPTIBLE SPECIES</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-positive aerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacillus cereus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Corynebacterium diphtheriae</em></p></td></tr><tr><td style="vertical-align:top"><p>Methicillin-susceptible<em> Staphylococcus </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus agalactiae</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-negative aerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Campylobacter</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Anaerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Actinomyces</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Capnocytophaga</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Clostridium perfringens</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Eubacterium</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Fusobacterium</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Gardnerella vaginalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Porphyromonas</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Prevotella</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Propionibacterium acnes</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Veillonella</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Other</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Chlamydia trachomatis</em></p></td></tr><tr><td style="vertical-align:top"><p>Leptospires</p></td></tr><tr><td style="vertical-align:top"><p><em>Mycoplasma hominis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Mycoplasma pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>VARIABLY SUSCEPTIBLE SPECIES</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>(&ge; 10% acquired resistance)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-positive aerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecium</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Erysipelothrix</em></p></td></tr><tr><td style="vertical-align:top"><p>Methicillin-resistant<em> Staphylococcus </em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pyogenes</em></p></td></tr><tr><td style="vertical-align:top"><p>Oral Streptococci</p></td></tr><tr><td style="vertical-align:top"><p><strong>Anaerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacteroides</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Clostridium </em>(other than<em> difficile </em>and<em> perfringens</em>)</p></td></tr><tr><td style="vertical-align:top"><p><em>Mobiluncus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Peptococcus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Peptostreptococcus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Propionibacterium acnes</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>NATURALLY RESISTANT SPECIES</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-positive aerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Corynebacterium jeikeium</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus </em>spp. (other than<em> Enterococcus faecium</em>)</p></td></tr><tr><td style="vertical-align:top"><p><em>Listeria</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Nocardia asteroides</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Rhodococcus equi</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Gram-negative aerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p>Non fermenting gram-negative bacilli</p></td></tr><tr><td style="vertical-align:top"><p><em>(Acinetobacter, Pseudomonas, etc. )</em></p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteria</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Legionella</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Branhamella catarrhalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pasteurella</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Anaerobes</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Clostridium difficile</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Other</strong></p></td></tr><tr><td style="vertical-align:top"><p>Mycobacteria</p></td></tr><tr><td style="vertical-align:top"><p><em>Ureaplasma urealyticum</em></p></td></tr></tbody></table><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Anti-parasitic activity</u></strong></p><p>Clindamycin shows <em>in vitro</em> and <em>in vivo</em> activity against <em>Toxoplasma gondii</em>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Following oral administration, clindamycin is rapidly and almost completely absorbed (90% of the ingested dose).</p><p>Simultaneous intake of food has practically no effect on plasma concentrations</p><p>&nbsp;</p><p>Distribution</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><u>Serum concentrations</u></em>: in healthy adults, peak plasma concentrations of about 2 - 3&nbsp;mg/L are observed one hour after oral administration of 150&nbsp;mg of clindamycin hydrochloride, and 4 - 5&nbsp;mg/L following oral administration of 300&nbsp;mg. Plasma concentrations then decrease slowly but remain above 1&nbsp;mg/L for more than 6 hours.</p><p>Plasma concentrations increase linearly with the dose taken.</p><p>Serum concentrations have been reported to be slightly lower in diabetic patients compared to healthy subjects.</p><p>The mean serum biological half-life of clindamycin is 2.5 hours.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><u>Plasma protein binding</u></em></p><p>Plasma protein binding is substantial: between 80 and 94%.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><u>Tissue and humoral circulation</u></em></p><p>Clindamycin is widely distributed at very high concentrations in extra- and intra-cellular fluids and in tissues.</p><p>Diffusion into CSF is very limited.</p><p>&nbsp;</p><p>Biotransformation</p><p>Clindamycin undergoes hepatic metabolism.</p><p>In vitro studies in human liver and intestinal microsomes indicated that clindamycin is predominantly oxidized by CYP3A4, with minor contribution from CYP3A5, to form clindamycin sulfoxide and a minor metabolite, N-desmethylclindamycin</p><p>&nbsp;</p><p>Elimination</p><p>About 10% of a dose is excreted in the urine as active drug and about 3.6% in the faeces; the remainder is excreted as inactive metabolites.</p><p>Clindamycin serum concentrations are not changed by haemodialysis or peritoneal dialysis.</p><p><em>Obese Patients</em></p><p>An analysis of pharmacokinetic data in obese and non obese pediatric patients aged 2 to less than 18 years and obese and non obese adults aged 18 to 20 years, shown based on a pharmacokinetic model that clindamycin clearance and volume of distribution normalized by total body weight are comparable regardless of obesity.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In oral embryo foetal development studies in rats and in subcutaneous embryo foetal development studies in rats and rabbits, no developmental toxicity was observed except at doses that produced maternal toxicity.</p><p>Genotoxicity studies haven&rsquo;t shown a genotoxic activity. No cancerogenesis studies have been conducted with clindamycin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Maize Starch, Talc, Magnesium Stearate, and Lactose Monohydrate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clindamycin is physicochemically incompatible with the following medicinal products: ampicillin, phenytoin, barbiturates, aminophylline, calcium gluconate, magnesium sulphate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	36 Months
	Do not use Dalacin C 150 & 300 mg after the expiry date which is stated on the card packaging or carton. The expiry date refers to the last day of that month.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dalacin C 150mg: 16 capsules in heat-formed blister packs (Aluminium foil/PVC).</p><p>Dalacin C 300mg: 16 capsules in heat-formed blister packs (Aluminium foil/PVC).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder
Pfizer Holding France 
23-25 Avenue Docteur Lannelongue  
75014 Paris
France 

MANUFACUTRED BY
Fareva Amboise
Zone Industrielle
29 route des Industries
37530 Pocé-sur-Cisse
France

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>